[Corrigendum] Engineered AXL<sup>‑ECD</sup>‑Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migration

Duan,Yanting; Hu,Bo; Qiao,Chunxia; Li,Xinying; Wang,Jing; Liu,Hao; Zhou,Tingting; Shen,Beifen; Lv,Ming; Feng,Jiannan

doi:10.3892/ol.2026.15698

August-2026 Volume 32 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August-2026 Volume 32 Issue 2

Full Size Image

Correction Open Access

[Corrigendum] Engineered AXL^‑ECD‑Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migration

Authors:
- Yanting Duan
- Bo Hu
- Chunxia Qiao
- Xinying Li
- Jing Wang
- Hao Liu
- Tingting Zhou
- Beifen Shen
- Ming Lv
- Jiannan Feng
View Affiliations / Copyright

Affiliations: State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P.R. China, Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China, Beijing Key Laboratory of Therapeutic Gene Engineering Antibody, Beijing 100850, P.R. China, Joint National Laboratory for Antibody Drug Engineering, Henan University, Zhengzhou, Henan 475004, P.R. China

Copyright: © Duan et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 343
|
Published online on: June 11, 2026

https://doi.org/10.3892/ol.2026.15698
Expand metrics +

Article

Oncol Lett 17: [Related article:] 5784–5792, 2019; DOI: 10.3892/ol.2019.10255

Following the publication of the above paper, it was drawn to the Editor's attention by an interested reader that, regarding the cell migration assay experiments shown in Fig. 3D on p. 5789, the ‘blank’ and the ‘Gas6+AXL-M2’ data panels were apparently matching, suggesting that the data in this figure had been assembled incorrectly.

Figure 3.

AXL−ECD-Fc-WT/M fusion proteins inhibited migration in SKOV3 and A549 cells. (A) Total AXL expression in cancer cell lines A549 (carcinoma), SKOV3 (human ovarian cancer cell) and 293T cells. (B) Flow cytometry analysis of the expression of AXL on the SKOV3 and A549 cell surface. Transwell assay results for high-affinity AXL−ECD-Fc-M1/M2 fusion proteins or low-affinity AXL−ECD-Fc-M3/M4 fusion proteins, which were added into cell culture medium, to capture free Gas6 in (C) A549 and (D) SKOV3 cells. ***P<0.005 and ****P<0.0001 vs. Gas6 (C2 group). AXL, AXL receptor tyrosine kinase ligand; Gas6, growth arrest-specific 6.

Upon consulting their original data, the authors have realized that this figure was inadvertently assembled incorrectly; specifically, the images for the SKOV3 Transwell assays (for the “blank” and “Gas6+AXL-M2” experiments) were inadvertently misplaced during typesetting. The revised version of Fig. 3, now showing the correct data panel for the “Gas6+AXL-M2” experiment, is shown on the next page. The authors regret the error that was made during the compilation of the original figure, and are grateful to the editor of Oncology Letters for allowing them the opportunity to publish this Corrigendum. Note that this error did not have a significant impact on the conclusions reported in this study. All the authors agree with the publication of this corrigendum; furthermore, they apologize to the readership for any inconvenience caused.

Journals